Director William P. Scully filed a Form 4 with the SEC on November 19, 2026, disclosing the open-market purchase of 50,000 ordinary shares of Prothena Corp Public Ltd Co (NASDAQ:PRTA) on November 17, 2026.
Key Highlights
- Transaction: William P. Scully acquired 50,000 ordinary shares (par value $0.01 per share) on November 17, 2026, with transaction code P (purchase).
- Weighted average price: Shares were purchased at a weighted average price of $8.0936, with individual transaction prices ranging from $7.9600 to $8.1700, inclusive.
- Direct holdings after transaction: Scully directly owns 1,027,000 ordinary shares following the reported purchase.
- Indirect holdings: An additional 529,000 shares are held indirectly by spouse, and 187,000 shares are held indirectly by Manatee Equity Fund LLC.
- Disclaimer: Scully disclaims beneficial ownership of the Manatee Equity Fund LLC shares except to the extent of his pecuniary interest therein.
- Role: Scully is identified as a director of Prothena Corp Public Ltd Co.
Scully's Open-Market Purchase and Resulting Ownership in Prothena
According to the filing, William P. Scully, a director of Prothena Corp Public Ltd Co, purchased 50,000 ordinary shares on November 17, 2026, through multiple open-market transactions. The weighted average purchase price was $8.0936 per share, with individual prices ranging from $7.9600 to $8.1700, inclusive. The filing notes that Scully undertakes to provide full information regarding the number of shares purchased at each separate price within those ranges, upon request by Prothena, any security holder of Prothena, or the staff of the Securities and Exchange Commission.
Following the transaction, the filing reports that Scully directly holds 1,027,000 ordinary shares. In addition to his direct position, the filing discloses two indirect holdings: 529,000 shares held by his spouse and 187,000 shares held by Manatee Equity Fund LLC. With respect to the Manatee Equity Fund LLC shares, the filing states that Scully disclaims beneficial ownership of those securities except to the extent of his pecuniary interest therein.
The Form 4 was signed by Reid E. Buchanan by power of attorney from William P. Scully and filed on November 19, 2026. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
Prothena Corp Public Ltd Co director William P. Scully reported a purchase of 50,000 ordinary shares on November 17, 2026, at a weighted average price of $8.0936, bringing his direct beneficial ownership to 1,027,000 shares, with additional indirect holdings of 716,000 shares combined.




Please wait processing your request...